Related Experiment Video
Updated: Jun 24, 2026
07:13
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
Genomic classifiers in colon cancer - clinical utility
1Division of Biostatistics, Mayo Clinic, Rochester, MN.
Gastrointestinal Cancer Research : GCR
|April 4, 2009
Summary
Developing accurate genomic classifiers for colon cancer requires careful methodology. This ensures reliable prediction of patient prognosis and treatment response, avoiding over-optimistic performance assessments.
Area of Science:
- Biomedical Informatics
- Oncology
- Genomics
Background:
- Technological advancements enable the creation of predictive algorithms using diverse data types (genomic, proteomic, pathologic).
- Potential for over-optimistic performance assessment exists without rigorous experimental design in classifier development.
Purpose of the Study:
- To outline a multi-step methodology for developing and assessing genomic classifiers for colon cancer.
- To address critical factors influencing the reliability and clinical utility of predictive algorithms.
Main Methods:
- Describing a systematic approach for genomic classifier development and validation.
- Emphasizing assay stability, patient cohort selection, data segregation (learning/validation), and inclusion of prognostic factors (e.g., staging).
Main Results:
- Highlighting the importance of examining relevant performance characteristics for clinical assessment.
- Discussing the necessity of prospective versus retrospective confirmation for robust validation.
Conclusions:
- Rigorous methodology is crucial for developing reliable genomic classifiers in colon cancer.
- Careful validation and assessment are essential to ensure accurate prediction of prognosis and therapeutic response.
Related Concept Videos
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...